Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trialBreast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health InitiativeLow-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification TrialCalcium plus vitamin D supplementation and the risk of colorectal cancerPredictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial.Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.A pooled analysis of vitamin D dose requirements for fracture prevention.Calcium plus vitamin D supplementation and the risk of fractures.Objective physical activity measurement in the osteoarthritis initiative: Are guidelines being met?Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women's Health Initiative (WHI).Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trialsCalcium plus vitamin D supplementation has limited effects on femoral geometric strength in older postmenopausal women: the Women's Health Initiative.The role of hormone therapy and calcium plus vitamin D for reduction of bone loss and risk for fractures: lessons learned from the Women's Health Initiative.Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.Serum 25-hydroxyvitamin D concentrations and risk for hip fracturesCalcium, vitamin D supplementation, and physical function in the Women's Health InitiativeCalcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health InitiativeCardiovascular disease and cognitive decline in postmenopausal women: results from the Women's Health Initiative Memory Study.A Pooled Analysis of Vitamin D Dose
P50
Q27860743-3f36f8c1-4ecc-625b-bb74-992449cdcabfQ28165551-4b0f4436-4a81-14b6-962b-3a7e6b39d3eaQ28296300-ffd770f1-450f-6cad-37ad-2e0c944e0e69Q28297713-74fa5351-4ce9-fa18-a410-a4d0b82be867Q33790554-47b9d22e-4edf-44d4-3791-81d0a98cb0fdQ34266403-95d5512b-4b36-65cf-2c87-d7556a4ad71dQ34286007-949f056a-4dca-9ce5-85fa-16ba67b9fd94Q34495055-79aadea2-46a5-5522-e278-4e98e2f50774Q35490120-a4530c73-4db9-d18f-b965-2e54f3593770Q35832404-136fd0ba-4396-79c0-0aad-b6ab1466a849Q36134810-41494625-4c5c-aecf-2657-3c4068720dbaQ37053045-d1a287d1-4f3f-9add-2704-fc3ea61726eeQ37145381-e934b60d-48c7-d5c3-5662-10a566d5e376Q37321697-e7bf25d5-4174-1024-1df3-371c0498e802Q37345469-1c04bc47-468c-f055-6ad6-6cb7cfad0337Q37419523-b0ab36c5-429d-2817-8552-ae24f9dcda80Q37441147-98f52f1e-4549-12e3-f76e-48bf1c22b027Q37457697-1da25591-42fe-3362-62ba-009c1b47d279Q58215580-5d15cb97-42a7-04e5-4453-7e22b1173758
P50
description
Amerikaans wetenschapster
@nl
Professor of endocrinology, diabetes and metabolism
@en
name
Rebecca D. Jackson
@en
Rebecca D. Jackson
@es
Rebecca D. Jackson
@nl
type
label
Rebecca D. Jackson
@en
Rebecca D. Jackson
@es
Rebecca D. Jackson
@nl
altLabel
R D Jackson
@en
R. D. Jackson
@en
RD Jackson
@en
Rebecca Jackson
@en
prefLabel
Rebecca D. Jackson
@en
Rebecca D. Jackson
@es
Rebecca D. Jackson
@nl
P214
P244
P106
P21
P214
P244
P31
P569
1955-01-01T00:00:00Z
P734
P7859
lccn-n92806285